Zenas BioPharma shares fall after Phase 3 obexelimab data in IgG4-RD showed a 56% flare risk reduction, as investors weigh ...
Presently, their therapeutic choices consist of anesthetics like ketamine, psychedelics such as psilocybin or various forms ...
Olema Pharmaceuticals (OLMA) earns a "Strong Buy" rating, driven by advancing palazestrant for 1st-line ER+/HER2- metastatic ...
Subject enrollment expected to begin in Q1 2026CDI-988 is the first oral broad-spectrum antiviral drug candidate for potential prevention of norovirus outbreaks and treatment of acute viral gastroente ...
Paper: Doctors Should Screen For ‘Problematic Chatbot Use’ As New Mental Health Risk Factor In A Nutshell One in ten ...
It wasn't exactly a surprise after months of leaks and speculation, but Nvidia CEO Jensen Huang (in perhaps his finest ...
You can pick a custom keyboard shortcut, and you can decide to simply press that shortcut instead of pressing and holding it.
FDA grants AXS-05 Priority Review designation and sets PDUFA action goal date of April 30, 2026 NEW YORK, Dec. 31, 2025 ...
The US FDA approved 46 new drugs in 2025, despite a tumultuous year at the regulatory agency.
America’s cost-of-living problem is simple math: Inflation spiked several years ago and paychecks haven’t had enough time to catch up. The latest jobs report revealed Tuesday that the problem got even ...
Health on MSN
What Happens to Your Body When You Take Ashwagandha
Ashwagandha is an herb that may have many applications based on its purported anti-anxiety, anti-inflammatory, antioxidant, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback